FDA.reportPublic FDA data

Butenafine Hydrochloride

Manufacturer
MEIJER DISTRIBUTION INC | Sun Pharma Canada Inc.
Effective date
2026-09-03
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
daily-update
Hydrated at
2026-09-08 02:02:17

Label at a glance#

ProductButenafine Hydrochloride
Active ingredientBUTENAFINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown. cures most jock itch and ringworm relieves itching, burning, cracking, and scaling which accompany these conditions

Dosage and administration

adults and children 12 years and older: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot between the toes: apply to affected skin between and around the toes twice a day for 1 week (morning and night), or once a day for 4 weeks, or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and...

Storage and handling

do not use if seal on tube is broken or not visible store between 20º to 25º C (68º to 77º F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Butenafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown.
  • cures most jock itch and ringworm
  • relieves itching, burning, cracking, and scaling which accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on nails or scalp
  • in or near the mouth or the eyes
  • for vaginal yeast infections

OTC - WHEN USING SECTION

When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if too much irritation occurs or irritation gets worse

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and older:
    • use the tip of the cap to break the seal and open the tube
    • wash the affected skin with soap and water and dry completely before applying
    • for athlete's foot between the toes: apply to affected skin between and around the toes twice a day for 1 week (morning and night), or once a day for 4 weeks, or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.

      Apply between and around the toes
      FigureFigure
      1 week twice a day or 4 weeks once a day

    • for jock itch and ringworm: apply once a day to affected skin for 2 weeks or as directed by a doctor.
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • do not use if seal on tube is broken or not visible
  • store between 20º to 25º C (68º to 77º F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetyl alcohol, glycerin, glyceryl monostearate SE, polyoxyethylene (23) cetyl ether, propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, trolamine, white petrolatum

Questions?

OTC - QUESTIONS SECTION

Call 1-866-923-4914

SPL UNCLASSIFIED SECTION

DIST. BY MEIJER DISTRIBUTION, INC.
GRAND RAPIDS, MI 49544

www.meijer.com

Made in Canada

PRINCIPAL DISPLAY PANEL - 30 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

meijer ®

PRESCRIPTION STRENGTH
Antifungal Cream
BUTENAFINE HYDROCHLORIDE CREAM 1% | ANTIFUNGAL

Clinically Proven to Cure Most Athlete's Foot between the Toes

Contains the Drug:
Butenafine
Hydrochloride

NET WT 30 g (1 oz)

CartonCarton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
79481-0086-12025-02-11C16284748780-12cef2736-6716-d83d-e063-dadaa90ab31fButenafine Hydrochloride
79481-0086-12025-02-11C16284748780-12cef2736-6716-d83d-e063-dadaa90ab31fButenafine Hydrochloride
79481-0086-12025-01-30C16284748780-12cef2736-6716-d83d-e063-dadaa90ab31fButenafine Hydrochloride
79481-0086-12025-01-30C16284748780-12cef2736-6716-d83d-e063-dadaa90ab31fButenafine Hydrochloride

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79481-008679481-0086-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
NameUNIIKind
BUTENAFINE HYDROCHLORIDER8XA2029ZIACTIB
BENZYL ALCOHOLLKG8494WBHIACT
CETYL ALCOHOL936JST6JCNIACT
GLYCERINPDC6A3C0OXIACT
GLYCERYL STEARATE SEFCZ5MH785IIACT
CETETH-23495CTZ441VIACT
PROPYLENE GLYCOL DICAPRYLATE581437HWX2IACT
WATER059QF0KO0RIACT
SODIUM BENZOATEOJ245FE5EUIACT
STEARIC ACID4ELV7Z65APIACT
TROLAMINE9O3K93S3TKIACT
PETROLATUM4T6H12BN9UIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
52025-07-03full-release2026-06-01 01:06:29

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A205181-001BUTENAFINE HYDROCHLORIDEBUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1684e616aacf4f…
2026-08-18 06:07:402026-07A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1674a2ff9319b5…
2022-03-09 01:35 UTC2022-03A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-1687673890dc5c…
2021-03-12 10:30 UTC2021-03A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-165aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-168869cabd3fbd…
2020-11-12 02:37 UTC2020-11A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16c0c555d07b60…
2019-12-14 00:12 UTC2019-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-163f01610625f2…
2019-09-15 20:21 UTC2019-09A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16b00525d2431f…
2019-07-19 19:46 UTC2019-07A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-166a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-161c564ffb4f44…
2023-12-20 04:57 UTC2023-12A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-169b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-163f0d92c62455…
2023-05-13 08:27 UTC2023-05A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16053a50430f4f…
2023-01-26 05:58 UTC2023-01A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-163bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-163a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A205181-001BUTENAFINE HYDROCHLORIDE1%CREAM / TOPICAL2017-11-16f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Butenafine HydrochlorideBUTENAFINE HYDROCHLORIDEMEIJER DISTRIBUTION INC4e88068b-1449-43b4-9c7c-4ad8e877459b2026-09-03WarningsExact identifier
ndc (package): 79481-0086-1
ndc (product): 79481-0086
ndc11 (package): 79481008601
spl id: 5a993dc7-3490-c2a8-e063-6394a90a4637
spl set id: 4e88068b-1449-43b4-9c7c-4ad8e877459b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.